177 related articles for article (PubMed ID: 7599153)
21. Incorporation of hexose nucleoside analogues into oligonucleotides: synthesis, base-pairing properties and enzymatic stability.
Augustyns K; Vandendriessche F; Van Aerschot A; Busson R; Urbanke C; Herdewijn P
Nucleic Acids Res; 1992 Sep; 20(18):4711-6. PubMed ID: 1329028
[TBL] [Abstract][Full Text] [Related]
22. Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras.
Monia BP; Johnston JF; Sasmor H; Cummins LL
J Biol Chem; 1996 Jun; 271(24):14533-40. PubMed ID: 8662854
[TBL] [Abstract][Full Text] [Related]
23. RNase H sequence preferences influence antisense oligonucleotide efficiency.
Kielpinski LJ; Hagedorn PH; Lindow M; Vinther J
Nucleic Acids Res; 2017 Dec; 45(22):12932-12944. PubMed ID: 29126318
[TBL] [Abstract][Full Text] [Related]
24. Hybridization specificity, enzymatic activity and biological (Ha-ras) activity of oligonucleotides containing 2,4-dideoxy-beta-D-erythro-hexopyranosyl nucleosides.
Augustyns K; Godard G; Hendrix C; Van Aerschot A; Rozenski J; Saison-Behmoaras T; Herdewijn P
Nucleic Acids Res; 1993 Oct; 21(20):4670-6. PubMed ID: 7694231
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biophysical properties of carbamate-locked nucleic acid (LNA) oligonucleotides with potential antisense applications.
Thorpe C; Epple S; Woods B; El-Sagheer AH; Brown T
Org Biomol Chem; 2019 May; 17(21):5341-5348. PubMed ID: 31099373
[TBL] [Abstract][Full Text] [Related]
26. Specific inhibition of influenza virus RNA polymerase and nucleoprotein gene expression by circular dumbbell RNA/DNA chimeric oligonucleotides containing antisense phosphodiester oligonucleotides.
Abe T; Takai K; Nakada S; Yokota T; Takaku H
FEBS Lett; 1998 Mar; 425(1):91-6. PubMed ID: 9541013
[TBL] [Abstract][Full Text] [Related]
27. Structural features in the HIV-1 repeat region facilitate strand transfer during reverse transcription.
Berkhout B; Vastenhouw NL; Klasens BI; Huthoff H
RNA; 2001 Aug; 7(8):1097-114. PubMed ID: 11497429
[TBL] [Abstract][Full Text] [Related]
28. Locked nucleic acids: a promising molecular family for gene-function analysis and antisense drug development.
Orum H; Wengel J
Curr Opin Mol Ther; 2001 Jun; 3(3):239-43. PubMed ID: 11497347
[TBL] [Abstract][Full Text] [Related]
29. Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids.
Lima WF; Crooke ST
Biochemistry; 1997 Jan; 36(2):390-8. PubMed ID: 9003192
[TBL] [Abstract][Full Text] [Related]
30. Probing alternative foldings of the HIV-1 leader RNA by antisense oligonucleotide scanning arrays.
Ooms M; Verhoef K; Southern E; Huthoff H; Berkhout B
Nucleic Acids Res; 2004; 32(2):819-27. PubMed ID: 14762209
[TBL] [Abstract][Full Text] [Related]
31. Antisense hairpin loop oligonucleotides as inhibitors of expression of multidrug resistance-associated protein 1: their stability in fetal calf serum and human plasma.
Rebowski G; Wójcik M; Boczkowska M; Gendaszewska E; Soszyński M; Bartosz G; Niewiarowski W
Acta Biochim Pol; 2001; 48(4):1061-76. PubMed ID: 11995968
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and investigation of deoxyribonucleic acid/locked nucleic acid chimeric molecular beacons.
Yang CJ; Wang L; Wu Y; Kim Y; Medley CD; Lin H; Tan W
Nucleic Acids Res; 2007; 35(12):4030-41. PubMed ID: 17557813
[TBL] [Abstract][Full Text] [Related]
33. Sugar modified oligonucleotides: synthesis, nuclease resistance and base pairing of oligodeoxynucleotides containing 1-(4'-thio-beta-D-ribofuranosyl)-thymine.
Bellon L; Morvan F; Barascut JL; Imbach JL
Biochem Biophys Res Commun; 1992 Apr; 184(2):797-803. PubMed ID: 1315535
[TBL] [Abstract][Full Text] [Related]
34. Carba-LNA-5MeC/A/G/T modified oligos show nucleobase-specific modulation of 3'-exonuclease activity, thermodynamic stability, RNA selectivity, and RNase H elicitation: synthesis and biochemistry.
Upadhayaya R; Deshpande SG; Li Q; Kardile RA; Sayyed AY; Kshirsagar EK; Salunke RV; Dixit SS; Zhou C; Földesi A; Chattopadhyaya J
J Org Chem; 2011 Jun; 76(11):4408-31. PubMed ID: 21500818
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of inhibition of in vitro dimerization of HIV type I RNA by sense and antisense oligonucleotides.
Skripkin E; Paillart JC; Marquet R; Blumenfeld M; Ehresmann B; Ehresmann C
J Biol Chem; 1996 Nov; 271(46):28812-7. PubMed ID: 8910525
[TBL] [Abstract][Full Text] [Related]
36. Hybridization of antisense oligonucleotides with the 3'part of tRNA(Phe).
Petyuk VA; Zenkova MA; Giege R; Vlassov VV
FEBS Lett; 1999 Feb; 444(2-3):217-21. PubMed ID: 10050762
[TBL] [Abstract][Full Text] [Related]
37. An overview of sugar-modified oligonucleotides for antisense therapeutics.
Prakash TP
Chem Biodivers; 2011 Sep; 8(9):1616-41. PubMed ID: 21922654
[TBL] [Abstract][Full Text] [Related]
38. Improved anti-herpes simplex virus type 1 activity of a phosphodiester antisense oligonucleotide containing a 3'-terminal hairpin-like structure.
Poddevin B; Meguenni S; Elias I; Vasseur M; Blumenfeld M
Antisense Res Dev; 1994; 4(3):147-54. PubMed ID: 7849485
[TBL] [Abstract][Full Text] [Related]
39. Alpha beta chimeric antisense oligonucleotides: synthesis and nuclease resistance in biological media.
Gottikh M; Bertrand JR; Baud-Dematteï MV; Lescot E; Giorgi-Renault S; Shabarova Z; Malvy C
Antisense Res Dev; 1994; 4(4):251-8. PubMed ID: 7734939
[TBL] [Abstract][Full Text] [Related]
40. Expanding the design horizon of antisense oligonucleotides with alpha-L-LNA.
Frieden M; Christensen SM; Mikkelsen ND; Rosenbohm C; Thrue CA; Westergaard M; Hansen HF; Ørum H; Koch T
Nucleic Acids Res; 2003 Nov; 31(21):6365-72. PubMed ID: 14576324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
